Get yourself updated on key emerging technology markets

Know about our market intelligence coverage in key sectors

Product is added to your Wishlist
Global Next Generation Implants Market

Global Next Generation Implants (NGI) Market –Analysis and Forecast (2017-2023) (Focus on Country Analysis, Comparative Analysis between Conventional and NG Implants (Application & Region), Patent Landscape, Market Share Analysis and Competitive Insights)

The global next generation implants market is estimated to grow over $3.9 billion by 2023. On the other hand, the conventional implants market is estimated to grow over $103 billion in 2023. On the basis of application, the market is segmented into orthopedic, cardiovascular, dental, ocular and other implants.

SKU: BH030A
Published Year: 2017
 
 

The medical implants market is a large market with implants for various applications. As the world population is ageing, the prevalence of age related degenerating diseases is increasing. As per World Health Organization (WHO), the number of people aged 60 years & above will rise to 1.4 billion by 2030. Due to increase in the geriatric population & improved life expectancy, the number of age related diseases has also increased. This is the major contributor to the increased demand of the medical implant devices. The devices can be of permanent or temporary nature depending on the application.

The medical implants can be categorised based on the application into orthopaedic, cardiovascular, ocular, dental and others. These implants can be made of different raw materials such as metals and its alloys, ceramics, polymers, biologicals and others. The market analysis includes an in-depth examination of the key ecosystem players and key strategies & developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities and challenges) and industry analysis. 

The purpose of the study is to gain a holistic view of the next generation implants market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the solutions allied with the medical implants market. The market has been segmented by ‘application’, ‘raw material’ and ‘geographical regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global next generation implants market with the help of key factors driving the market, threats that can possibly inhibit the overall market growth, emergence of next generation of implants and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global next generation implants market and assesses the factors governing the same.

The answers to the following key questions can be derived from this report:

•    What are the major market drivers, challenges and opportunities in the global next generation implants market and their case studies?
•    How the medical implants market evolve and what is its scope in the future?
•    What is the market share of the leading segments and sub-segments of the global next generation implants market in 2016 and 2023?
•    How will each segment of the global next generation implants market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2023?
•    What are the influencing factors that may affect the market share of the key players?
•    How will the industry evolve during the forecast period between 2016 and 2023?
•    What are the key developmental strategies implemented by the key players to stand out in this market?
•    What will be the growth rate of different segments during the forecast period? Which is the leading segment by application and raw material used?
•    Who are the key players for the next generation of implants market?
•    How the market has been segmented on the basis of application? 
•    Which geographical location will dominate the next generation implants market?

The key players which have significant contributions to the biologics drug discovery market are Smith & Nephew plc, Orthofix Holdings, Inc. Medtronic Public Limited Company, LivaNova PLC, Edwards Lifesciences Corporation, Globus Medical Inc., Johnson & Johnson and Zimmer Biomet Holdings Inc. among others.

TABLE OF CONTENT
Executive Summary
1 Report Scope
1.1. Scope of the Report
1.2. Global Next Generation Implant Market Segmentation
1.3 Key Learnings
1.4 Research Methodology
1.4.1. Data Triangulation
1.4.2. Key Data Points from Secondary Sources
1.4.3. Key Data Points from Primary Sources
1.4.4. Top-Down Approach (Segmental Analysis)
1.4.5. Bottom-Up Approach (Segmental Analysis)
1.4.6. Assumptions and Limitations
1.4.7. Data and Prediction Modelling
2 Market Overview
2.1 Introduction
2.2 Characteristics of Implant
2.3. Recent Advancements
3 Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
4 Industry Insights
4.1 Regulatory Scenario
4.2. Patent Landscape
5 Competitive Landscape
5.1.  Share of Key Development and Strategies
5.1.1 Regulatory Body Clearance
5.1.2 New Product Launches and Developments
5.1.3 Mergers & Acquisition
5.1.4 Agreements, Joint Ventures and Partnerships
5.1.5 Business Expansion
5.1.6 Awards, Certifications and Other Developments
5.2.  Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Competitive Rivalry
5.3.  Value Chain Analysis
6 Global Next Generation Implants Market, by Application
6.1. Market Overview
6.1.1. Orthopedic Implants
6.1.2. Cardiovascular Implants
6.1.3. Ocular Implants
6.1.4. Dental Implants
6.1.6. Others
7 Global Next Generation Implants Market, by Material
7.1. Introduction
7.2. Characteristics
7.3. Metals & Metal Alloys
7.4. Ceramics
7.5. Polymers
7.6. Biologics
7.7 Others
8 Global Next Generation Implants Market, by Geography
8.1. Introduction
8.2. North America
8.2.1 The U.S.
8.2.2 Canada
8.3. Europe
8.3.1 Germany
8.3.2 France
8.3.3 U.K.
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4. Asia-Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of APAC
8.5. Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6. Rest of the World
8.6.1 KSA
8.6.2 Israel
8.6.3 U.A.E.
8.6.4 Russia
8.6.5 Others
9 Company Profiles
9.1. Abbott Laboratories
9.2. Arthrex
9.3. Biotronik SE & Co. KG
9.4. BOSTON SCIENTIFIC CORPORATION
9.5. C. R. BARD, INC.
9.6. DANAHER CORPORATION
9.7. DENTSPLY SIRNA Inc.
9.8. Edwards Lifesciences Corporation
9.9. ENDO INTERNATIONAL PLC
9.10. Globus Medical Inc.
9.11 Integer Holdings Corporation
9.12. Integra LifeSciences Corporation
9.13. Institut Straumann AG
9.14. JOHNSON & JOHNSON
9.15. LifeNet Health, Inc.
9.16. LivaNova PLC
9.17. MEDTRONIC PUBLIC LIMITED COMPANY
9.18. Novartis International AG
9.19. NUVASIVE, INC.
9.20. Orthofix Holdings, Inc.
9.21. Smith & Nephew plc
9.22. STRYKER CORPORATION
9.23. SYMETIS SA
9.24 TERUMO CORPORATION
9.25 W. L. Gore & Associates, Inc.
9.26 Wright Medical Group N.V
9.27 Zimmer Biomet Holdings Inc
List of Tables
1 Global Implants Market (2016 & 2023)
2 Percentage of Total Regional Population Aged 65 Years & Above: 2015 & 2030
3 Regulatory Scenario Across the World
4 Patents Granted to Companies
5 Patents Granted to Individuals/ Universities
6 Regulatory Body Clearance
7 New Product Launches & Development
8 Merger & Acquisitions
9 Agreements, Joint Ventures & Partnerships
10 Business Expansion
11 Factors Affecting Bargaining Power of Suppliers
12 Factors Affecting the Bargaining Power of Buyer
13 Factors Affecting Threat of New Entrant
14 Factors Affecting the Threat of Substitute
15 Factors Affecting the Intensity of Competitive Rivalry
16 Global Joint Reconstruction, by Type, 2016-2023 ($Million) 
17 Global Spinal Implants, by Type, 2016-2023 ($Million) 
18 Cardiac Devices Used in U.S.
19 Arthroplasty Procedures in U.S. 
20 Total Knee Replacement Procedures
21 Number of Joint Replacement Procedures as per National Joint Registry
22 Joint Replacement Procedures in Italy
23 Cardiac Pacemakers Implanted in Different Countries of Europe
24 ICDs Implanted in Different Countries of Europe
25 Percentage of Population Aged 60 Years or Above
26 Number of Procedures Performed in India
27 Joint Replacement Procedures Performed in Austra
28 Number of Procedures Performed in New Zealand
29 Different Cardiac Implant Procedures Performed in APAC Countries
30 Percentages of Population Aged 60 or Over
31 Overview: Abbott Laboratories 
32 Overview: Arthrex
33 Overview: Biotronik SE & Co. KG
34 Overview: BOSTON SCIENTIFIC CORPORATION
35 Overview: C. R. BARD, INC.
36 Overview: DANAHER CORPORATION
37 Overview: DENTSPLY SIRONA Inc.
38 Overview: Edwards Lifesciences Corporation
39 Overview: ENDO INTERNATIONAL PLC  
40 Overview: Globus Medical Inc.
41 Overview: Integer Holdings Corporation
42 Overview: Integra LifeSciences Corporation.
43 Overview: Institut Straumann AG
44 Overview: JOHNSON & JOHNSON
45 Overview: LifeNet Health, Inc.
46 Overview: LivaNova PLC
47 Overview: MEDTRONIC PUBLIC LIMITED COMPANY
48 Overview: Novartis International AG 
49 Overview: NUVASIVE, INC.
50 Overview: Orthofix Holdings, Inc.
51 Overview: Smith & Nephew plc 
52 Overview: STRYKER CORPORATION
53 Overview: SYMETIS SA
54 Overview: TERUMO CORPORATION
55 Overview: W. L. Gore & Associates, Inc.
56 Overview: Wright Medical Group N.V
57 Overview: Zimmer Biomet Holdings Inc
List of Figures
1 Classification of Implants
2 Global Implants Market, 2016-2023 ($Million)
3 Global Implants Market Value by Geography, 2016 & 2023 ($Million)
4 Global Conventional Implants Market, 2016-2023 ($Million)
5 Global Next Generation Implants Market, 2016-2023 ($Million)
6 Global Implants Market, by geography, 2016
7 Global Implants Market, by geography, 2023
8 Global Conventional Implants Market, by Application, 2016
9 Global Conventional Implants Market, by Application, 2023
10 Global Next Generation Implant Market Segmentation
11 Research Methodology
12 Data Triangulation
13 Key Data Points From Secondary Sources 
14 Secondary Data Sources
15 Key Data Points From Primary Sources 
16 Top-Down  Approach (Segmental Analysis)
17 Bottom-Up Approach (Segmental Analysis)
18 Assumptions and Limitations
19 Data and Prediction Modelling
20 Evolution of Pacemaker
21 Evolution of ICDs
22 Total Number of Strategies & Developments
23 Merger & Acquisitions
24 Porter’s Five Forces Analysis
25 Value Chain Analysis
26 Classification of Implants
27 Figure Global Conventional Implants, 2016-2023 ($Million) 
28 Figure Global Next Generation Implants, 2016-2023 ($Million) 
29 Figure Global Conventional Implants Market, by Geography, 2016-2023 ($Million)
30 Global Next Generation Implants Market, by Geography, 2016-2023 ($Million)
51 Classification of Orthopaedic Implants
32 Global Conventional Orthopaedic Implants, 2016-2023 ($Million) 
33 Global Next Generation Orthopaedic Implants, 2016-2023 ($Million) 
34 Global Conventional Orthopaedic Implants, by Type, 2016-2023 ($Million) 
35 Global Next Generation Orthopaedic Implants, by Type, 2016-2023 ($Million) 
36 Global Conventional Orthopaedic Implants, by Geography, 2016-2023 ($Million) 
37 Global Next Generation Orthopaedic Implants, by Geography, 2016-2023 ($Million) 
38 Global Joint Reconstruction, by Type, 2016-2023 ($Million) 
39 Global Spinal Implants, by Type, 2016-2023 ($Million) 
40 Classification of Cardiovascular Implants
41 Global Conventional Cardiovascular Implants, 2016-2023 ($Million) 
42 Global Next Generation Cardiovascular Implants, 2016-2023 ($Million) 
43 Global Conventional Cardiovascular Implants, by Geography, 2016-2023 ($Million) 
44 Global Conventional Cardiovascular Implants, by Type, 2016-2023 ($Million) 
45 Global Next Generation Cardiovascular Implants, by Type, 2016-2023 ($Million) 
46 Classification of Neurostimulator Implants
47 Classification of Ocular Implants
48 Global Conventional Ocular Implants, 2016-2023 ($Million)
49 Global Conventional Ocular Implants, by Geography, 2016-2023 ($Million) 
50 Classification of Dental Implants
51 Global Conventional Dental Implants, 2016-2023 ($Million) 
52 Global Next Generation Dental Implants, 2016-2023 ($Million) 
53 Global Conventional Dental Implants, by Type of Material, 2016-2023 ($ Million)
54 Global Conventional Dental Implants, by Geography, 2016-2023 ($Million) 
55 Global Next Generation Dental Implants, by Geography, 2016-2023 ($Million) 
56 Global Conventional Implants, Others, 2016-2023 ($Million)
57 Global Conventional Other Implants, by Geography, 2016-2023 ($Million) 
58 Global Conventional Implants Market, by Material, 2016-2023 ($Million)
59 Global Conventional Implants Market, Metals & Metal Alloys, 2016-2023 ($Million)
60 Global Conventional Implants Market, Ceramics, 2016-2023 ($Million)
61 Global Conventional Implants Market, Polymers, 2016-2023 ($Million)
62 Global Conventional Implants Market, Biologicals & Biological Substitutes, 2016-2023 ($Million)
63 Global Conventional Implants Market, Others, 2016-2023 ($Million)
64 Global Implants Market,  by Geography, 2016-2023 ($Million)
65 Global Conventional Implants,by Geography, 2016-2023 ($Million) 
66 Global Next Generation Implants, by Geography, 2016-2023 ($Million) 
67 Global Implants Market, North America, 2016-2023 ($Million) 
68 Global Conventional Implants, North America, 2016-2023 ($Million) 
69 Global Next Generation Implants, North America, 2016-2023 ($Million) 
70 The U.S. Conventional Implants Market, 2016-2023 ($Million)
71 Canada Conventional Implants Market, 2016-2023 ($Million)
72 Global Implants Market, Europe, 2016-2023 ($Million) 
73 Global Conventional Implants, Europe, 2016-2023 ($Million) 
74 Global Next Generation Implants, Europe, 2016-2023 ($Million) 
75 The U.K. Conventional Implants Market, 2016-2023 ($Million)
76 Germany Conventional Implants Market, 2016-2023 ($Million)
77 France Conventional Implants Market, 2016-2023 ($Million)
78 Italy Conventional Implants Market, 2016-2023 ($Million)
79 Spain Conventional Implants Market, 2016-2023 ($Million)
80 Rest of Europe Conventional Implants Market, 2016-2023 ($Million)
81 Global Implants Market, Asia Pacific, 2016-2023 ($Million) 
82 Global Conventional Implants, Asia Pacific, 2016-2023 ($Million) 
83 Global Next Generation Implants, Asia Pacific, 2016-2023 ($Million) 
84 Japan Conventional Implants Market, 2016-2023 ($Million)
85 China Conventional Implants Market, 2016-2023 ($Million)
86 Australia Conventional Implants Market, 2016-2023 ($Million)
87 S.Korea Conventional Implants Market, 2016-2023 ($Million)
88 India Conventional Implants Market, 2016-2023 ($Million)
89 Rest of Asia Conventional Implants Market, 2016-2023 ($Million)
90 Global Implants Market, Latin America, 2016-2023 ($Million) 
91 Global Conventional Implants, Latin America, 2016-2023 ($Million) 
92 Global Next Generation Implants, Latin America, 2016-2023 ($Million) 
93 Brazil Conventional Implants Market, 2016-2023 ($Million)
94 Mexico Conventional Implants Market, 2016-2023 ($Million)
95 Rest of Latin America Conventional Implants Market, 2016-2023 ($Million)
96 Global Implants Market, Rest of the World 2016-2023 ($Million) 
97 Global Conventional Implants, Rest of the World, 2016-2023 ($Million) 
98 Global Next Generation Implants, Rest of the World, 2016-2023 ($Million) 
99 KSA Conventional Implants Market, 2016-2023 ($Million)
100 Israel Conventional Implants Market, 2016-2023 ($Million)
101 U.A.E. Conventional Implants Market, 2016-2023 ($Million)
102 Russia Conventional Implants Market, 2016-2023 ($Million)
103 Others Conventional Implants Market, 2016-2023 ($Million)
104 Abbott Laboratories: Overall Financials (2014-2016)
105 Abbott Laboratories: Net Revenue by Business Segment (2014-2016)
106 Abbott Laboratories: Net Revenue by Region (2014-2016)
107 Abbott Laboratories: SWOT Analysis
108 ARTHREX: Product Portfolio
109 Arthrex: SWOT Analysis
110 Biotronik SE & CO. KG: Product Portfolio
111 Biotronik SE & Co. KG: SWOT Analysis
112 BOSTON SCIENTIFIC CORPORATION: Product Portfolio
113 BOSTON SCIENTIFIC CORPORATION: Overall Financials (2014-2016)
114 BOSTON SCIENTIFIC CORPORATION: Net Revenue by Business Segment (2014-2016)
115 BOSTON SCIENTIFIC CORPORATION: Net Revenue by Region (2014-2016)
116 BOSTON SCIENTIFIC CORPORATION: Net Revenue by Cardiovascular Business Segment (2014-2016)
117 BOSTON SCIENTIFIC CORPORATION: Net Revenue by Rhythm Management Business Segment (2014-2016)
118 BOSTON SCIENTIFIC CORPORATION: Net Revenue by MedSurg Business Segment (2014-2016)
119 BOSTON SCIENTIFIC CORPORATION: SWOT Analysis
120 C. R. BARD, INC.: Product Portfolio
121 C. R. BARD, INC.: Overall Financials (2014-2016)
122 C. R. BARD, INC.: Net Revenue by Business Segment (2014-2016)
123 C. R. BARD, INC.: Net Revenue by Region (2014-2016)
124 C.R. BARD, INC.: SWOT Analysis
125 DANAHER CORPORATION: Product Portfolio
126 DANAHER CORPORATION: Overall Financials (2014-2016)
127 DANAHER CORPORATION: Net Revenue by Business Segment (2014-2016)
128 DANAHER CORPORATION: Net Revenue by Region (2014-2016)
129 DANAHER CORPORATION: SWOT Analysis
130 DENTSPLY SIRONA Inc.: Product Portfolio
131 DENTSPLY SIRONA Inc.: Overall Financials (2014-2016)
132 DENTSPLY SIRONA Inc.: Net Revenue by Business Segment (2014-2016)
133 DENTSPLY SIRONA Inc.: Net Revenue by Region (2014-2016)
134 DENTSPLY SIRONA Inc.: Net Revenue by Medical Product Type (2014-2016)
135 DENTSPLY SIRONA Inc.: SWOT Analysis
136 Edwards Lifesciences Corporation: Product Portfolio
137 Edwards Lifesciences Corporation: Overall Financials (2014-2016)
138 Edwards Lifesciences Corporation: Net Revenue by Business Segment (2014-2016)
139 Edwards Lifesciences Corporation: Net Revenue by Region (2014-2016)
140 Edwards Lifesciences Corporation: SWOT Analysis
141 ENDO INTERNATIONAL PLC: Product Portfolio
142 ENDO INTERNATIONAL PLC: Overall Financials (2014-2016)
143 ENDO INTERNATIONAL PLC: Net Revenue by Business Segment (2014-2016)
144 ENDO INTERNATIONAL PLC: SWOT Analysis
145 Globus Medical Inc.: Product Portfolio
146 Globus Medical Inc.: Overall Financials (2014-2016)
147 Globus Medical Inc.: Net Sales by Business Segment (2014-2016)
148 Globus Medical Inc.: Net Sales by Region (2014-2016)
149 Globus Medical Inc.: SWOT Analysis
150 Integer Holdings Corporation: Product Portfolio
151 Integer Holdings Corporation: Overall Financials (2014-2016)
152 Integer Holdings Corporation: Net Revenue by Business Segment (2014-2016)
153 Integer Holdings Corporation: Net Revenue by Region (2014-2016)
154 Integer Holdings Corporation: Net Revenue by Medical Business Segment (2014-2016)
155 Integer Holdings Corporation: SWOT Analysis
156 Integra LifeSciences Corporation: Product Portfolio
157 Integra LifeSciences Corporation: Overall Financials (2014-2016)
158 Integra LifeSciences Corporation: Net Revenue by Business Segment (2014-2016)
159 Integra LifeSciences Corporation: Net Revenue by Region (2014-2016)
160 Integra LifeSciences Corporation: SWOT Analysis
161 Institute Straumann AG: Product Portfolio
162 Institute Straumann AG: Overall Financials (2014-2016)
163 Institute Straumann AG: Net Revenue by Region (2014-2016)
164 Institute Straumann AG: SWOT Analysis
165 JOHNSON & JOHNSON: Product Portfolio
166 JOHNSON & JOHNSON: Overall Financials (2014-2016)
167 JOHNSON & JOHNSON: Net Revenue by Business Segment (2014-2016)
168 JOHNSON & JOHNSON: Net Revenue by Region (2014-2016)
169 JOHNSON & JOHNSON: Net Revenue by Medical Devices Business Segment (2014-2016)
170 JOHNSON & JOHNSON: Net Revenue by Orthopedic Subsegment (2014-2016)
171 JOHNSON & JOHNSON: SWOT Analysis
172 LifeNet Health, Inc.: Product Portfolio
173 LifeNet Health Inc.: SWOT Analysis
174 LivaNova PLC: Product Portfolio
175 Cyberonics: Overall Financials (2014-2015)
176 LivaNova PLC: Overall Financials (2016)
177 LivaNova PLC: Net Sales by Product Segment (2015-2016)
178 LivaNova PLC: Net Sales by Geography (2015-2016)
179 LivaNova PLC: SWOT Analysis
180 MEDTRONIC PUBLIC LIMITED COMPANY: Product Portfolio
181 MEDTRONIC PUBLIC LIMITED COMPANY: Overall Financials (2014-2016)
182 MEDTRONIC PUBLIC LIMITED COMPANY: Net Revenue by Business Segment (2014-2016)
183 MEDTRONIC PUBLIC LIMITED COMPANY: Net Revenue by Region (2014-2016)
184 MEDTRONIC PUBLIC LIMITED COMPANY: Net Revenue by Cardiac& Vascular Segment (2014-2016)
185 MEDTRONIC PUBLIC LIMITED COMPANY: Net Revenue by Restorative Therapies Segment (2014-2016)
186 MEDTRONIC PUBLIC LIMITED COMPANY: SWOT Analysis
187 Novartis International AG: Product Portfolio
188 Novartis International AG: Overall Financials (2014-2016)
189 Novartis International AG: Net Revenue by Business Segment (2014-2016)
190 Novartis International AG: Net Revenue by Region (2014-2016)
191 Novartis International AG: SWOT Analysis
192 NUVASIVE, INC.: Product Portfolio
193 NUVASIVE, INC.: Overall Financials (2014-2016)
194 NUVASIVE, INC.: Net Revenue by Business Segment (2014-2016)
195 NUVASIVE, INC.: Net Revenue by Region (2014-2016)
196 NUVASIVE, INC.: SWOT Analysis
197 Orthofix Holdings, Inc.: Product Portfolio
198 Orthofix Holdings, Inc.: Overall Financials (2014-2016)
199 Orthofix Holdings, Inc.: Net Revenue by Business Segment (2014-2016)
200 Orthofix Holdings, Inc.: Net Revenue by Region (2014-2016)
201 Orthofix Holdings Inc.: SWOT Analysis
202 Smith & Nephew plc: Product Portfolio
203 Smith & Nephew plc: Overall Financials (2014-2016)
204 Smith & Nephew plc: Net Revenue by Business Segment (2014-2016)
205 Smith & Nephew plc: Net Revenue by Region (2014-2016)
206 Smith & Nephew plc: SWOT Analysis
207 STRYKER CORPORATION: Product Portfolio
208 STRYKER CORPORATION: Overall Financials (2014-2016)
209 STRYKER CORPORATION: Net Revenue by Business Segment (2014-2016)
210 STRYKER CORPORATION: Net Revenue by Region (2014-2016)
211 STRYKER CORPORATION: Net Revenue by Orthopedic Business Segment (2014-2016)
212 STRYKER CORPORATION: Net Revenue by Neurotechnology & Spine Business Segment (2014-2016)
213 STRYKER CORPORATION: SWOT Analysis
214 SYMETIS SA: SWOT Analysis
215 TERUMO CORPORATION: Product Portfolio
216 TERUMO CORPORATION: Overall Financials (2013-2015)
217 TERUMO CORPORATION: Net Revenue by Business Segment (2013-2015)
218 TERUMO CORPORATION: Net Revenue by Region (2013-2015)
219 TERUMO CORPORATION: SWOT Analysis
220 W.L. Gore & Associates, Inc.: Product Portfolio
221 W.L. Gore & Associates, Inc.: SWOT Analysis
222 Wright Medical Group N.V.: Product Portfolio
223 Wright Medical Group N.V.: Overall Financials (2014-2016)
224 Wright Medical Group N.V.: Net Revenue by Business Segment (2014-2016)
225 Wright Medical Group N.V.: Net Revenue by Region (2014-2016)
226 Wright Medical Group N.V.: SWOT Analysis
227 Zimmer Biomet Holdings Inc.: Product Portfolio
228 Zimmer Biomet Holdings Inc.: Overall Financials (2014-2016)
229 Zimmer Biomet Holdings Inc.: Net Sales by Product Segment (2014-2016)
230 Zimmer Biomet Holdings Inc.: Net Sales by Geography (2014-2016)
231 Zimmer Biomet Holdings Inc: SWOT Analysis

As the world population is ageing, the prevalence of age related degenerating diseases is increasing. As per World Health Organization (WHO), the number of people aged 60 years & above will rise to 1.4 billion by 2030. Due to this increase in the geriatric population & improved life expectancy, the number of age related diseases has also increased. This is the major contributor to the increased demand of the medical implant devices. 

Medical implants are devices that are used to insert or graft into a patient’s body to function as a part or whole organ. As per U.S. FDA, an implant can be defined as a device or tissue that can be placed inside or on the surface of the body. These devices provide support to the existing organs or replace them or substitute the missing parts. Some implants are permanent in nature & stay lifelong in the patient’s body while others may be temporary. The permanent implants include stents, pacemakers, heart valves etc. Temporary implants are removed when no longer needed such as screws. Some of these provide structural & functional support such as cardiac valves, and joint replacement implants, while others can be life sustaining systems such as implantable pacemakers & defibrillators. The younger population is also a consumer group of these implants due to lifestyle changes. The increased prevalence of obesity, physical inactiveness, and increased consumption of fast food are also contributors to such diseases & hence add to the demand of implant devices.

The purpose of the study is to gain a holistic view of the global medical implants market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the solutions allied with the medical implants market including conventional and next generation implants. The market has been segmented into ‘application’, ‘raw material’ and ‘geographical regions’. 

The global next generation implants market is estimated to grow over $3.9 billion by 2023. On the other hand, the conventional implants market is estimated to grow over $103 billion in 2023. On the basis of application, the market is segmented into orthopedic, cardiovascular, dental, ocular and other implants. As per the raw material, the metals and its alloys are dominating the conventional implants market with an estimated value of $25 billion in 2016.

North America was estimated to be the leader in 2016 in conventional implants with a market value of $30 billion in 2016 mainly due to rising geriatric population and increased prevalence of diseases. The fastest growing market is expected to Asia Pacific with a CAGR of 8.7% from 2017 to 2023. The market is strongly driven by the technological advancement & evolution of implants. The use of better materials, automated surgeries, biological materials, personalised implants, better care, and decreased risk of infection are contributing to increased patients’ and physicians’ interest in the market.

The report provides in-depth SWOT analysis of different key players of the market, supported by extensive financial summary of each. Some of the key players are Abbott Laboratories, Smith & Nephew plc, Boston Scientific Corporation, Johnson & Johnson, Medtronic Public Limited Company, Wright Medical Group N.V, C.R.Bard, INC., Stryker Corporation, Globus Medical Inc., DENTSPLY SIRONA Inc., and Zimmer Biomet Holdings Inc among others.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields

OUR HAPPY CLIENTS


related reports

 

OUR CLIENTS